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LABORATORY INVESTIGATION
Decreased ATPase activity in adriamycin nephrosis is
independent of proteinuria
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and MACHIEL J. HARDONK
Department of Pathology and Centre for Medical Electron Microscopy, University of Groningen, The Netherlands
Decreased ATP-ase activity in adriamycin nephrosis is independent of
proteinurla. In previous studies from this laboratory it has been shown
that ATP-ase activity in situ in the glomerular basement membrane
(GBM) is clearly reduced in rats rendered nephrotic after treatment
with adriamycin (ADR). The question was raised whether this reduction
of ATP-ase activity in the GBM is due to toxic activity of ADR or rather
a result of the nephrotic condition per se. Therefore, we studied
ATP-ase activity using the cerium—based method in kidneys from
ADR-treated rats without proteinuria (48 hr after ADR injection), or
with proteinuria (—150 mg/24 hr) several weeks after ADR injection.
Also kidneys from rats rendered nephrotic by surgical ablation and from
non-nephrotic rats treated with local X-irradiation (2000 rads) as well as
from normal control rats were studied. The results show that in the
GBM of ADR-treated or irradiated rats, clear reduction of ATP-ase
activity is observed irrespective of their proteinuria, whereas in the
GBM of rats rendered nephrotic by renal ablation (—156 mg/24 hr mean
protein excretion) no reduction of enzyme activity is found. It is
concluded that decreased ATP-ase activity of the glomerular filtration
barrier in ADR-treated rats is due to an early toxic activity of this drug
and not a result of the nephrotic state per se. In view of the identical
results in X-irradiated rats, it is likely that ADR may act through
production of toxic radicals leading to damage of this membrane—as-
sociated enzyme system.
The nephrotoxicity of adriamycin (ADR) in the rat is well
documented [1—3], although the mechanism leading to glomer-
ular damage is poorly understood. Intravenous injection of
ADR into rats gives rise to increasing proteinuria reaching its
maximum level 28 days after injection of ADR [2]. In situ
activity of nucleoside di- and tri-phosphatases in the GBM of
the rat kidney has been recently demonstrated by Hardonk,
Kalicharan and Hulstaert [4], using the cerium based method
[5]. Employing this method we have found that in contrast to
normal control animals, the activity of ATPase in the glomeru-
lar basement membrane (GBM) as well as along the membranes
of the glomerular endothelial cells had clearly decreased in
ADR-treated rats [6].
The question emerged whether this reduction of ATPase
activity in the glomerular filtration barrier is due to the toxic
activity of ADR or rather to the nephrotic condition per Se.
Therefore, in the present study we have compared ATPase
activity at the ultrastructural level in the glomerular filtration
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barrier of rats rendered nephrotic by either ADR treatment or
by surgical ablation of the kidneys [7, 8]. Also kidneys from
normal rats and from non-nephrotic rats 48 hours after ADR
treatment were studied. Since similarities between the damag-
ing affects of ADR on the one hand, and X-irradiation on the
other hand have been suggested [9, 10], we have also studied
rats which had been exposed to local X-irradiation.
The results show that the ATPase activity was reduced in the
endothelial cell membranes and in the GBM of kidneys from
ADR-treated and X-irradiated rats, irrespective of their protein-
uria. In contrast, the glomerular filtration barrier in kidneys
from rats with proteinuria induced by surgical ablation did not
show reduced ATPase activity as compared with control rats. It
is concluded that the decrease of ATPase activity in GBM and
glomerular endothelial cell membranes of ADR treated rats is
apparently due to an early toxic activity of ADR and not a result
of the nephrotic condition per se.
Methods
Experimental animals
Female PVG/c, weighing 200 to 300 g, were used throughout
the study. Animals were fed with RMHP (Hope Farms,
Woerden, The Netherlands) and received water ad libitum.
Rats were divided into three experimental groups (group
II—IV) and one group (group I) of control animals.
Induction of proteinuria
Adriamycin nephrosis was induced in eight rats (groups II
and III) by a single i.v. injection of adriamycin solution in saline
(adryblastine, Laboratoire Roger Bellon, Neuilly sur Seine,
France) (0.5 ml, 8.5 mg of ADR per kg of body wt).
Four animals of this group were sacrificed on day 2 (group II),
and four animals between day 21 and day 35 depending on the
range of proteinuria (group III).
Five rats were rendered nephrotic by surgical ablation of
their kidneys according to Olsen [7]. The animals underwent
left nephrectomy under halothane N20-02 anaesthesia, and one
week later a fraction of approximately 5/6 of the right kidney
was eliminated by ligation of three or two extra renal branches
of the main renal artery. These rats were sacrificed when their
protein excretion exceeded 120 mg/24 hr.
Urine was collected from rats housed for 24 hours in meta-
bolic cages with free excess to water only, and protein excre-
tion was determined using the biuret method.
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Fig. 1. A. ATPase activity in a glomerular capillary seg,nent of normal rat kidney (group 1). Reaction product is present throughout the GBM with
relatively strong staining of the lamina rara interna. Reaction product is also present along the plasma membranes of endothelial and epithelial cells.
x 16,600. B. ATPase activity in the proximal tubule of normal rat kidney. Reaction product is present along the microvilli, the basal infoldings and
the basement membrane of the epithelial cells. x 7,700. Abbreviations are: c, capillary lumen; us, urinary space; t, tubular lumen; m, microvilli.
Table I. Proteinuria of experimental and control aminals
Treatment
Mean protein excretion
at the time of sacrifice
Group I non-treated control ratsN=3 <5mgI24hr
Group II adriamycin injected rats
8.5 mg/kg body wtN= 4 <5mgI24hr
Group 111 adriamycin injected rats
8.5 mg/kg body wtN=4 l50±5Omg/24hr
Group IV rats treated with surgical
renal ablation N = 5 156 70 mg/24 hr
Group V local X-irradiated rats
2000 rads N = 5 <5 mg/24 hr
X-ray irradiation
Five rats (group V) received dorsal irradiation (2000 rads)
upon the kidney region, whereas other parts of the body were
shielded with lead shields [II].
Proteinuria was measured subsequently and these animals
were sacrificed 24 hours after irradiation.
Electron microscopy (EM) and enzyme histochemistry
Kidneys were perfused via the arteria renalis and processed
for EM and enzyme histochemistry as described elsewhere with
minor modifications [4]. Briefly, perfusion was carried out for
one minute with 2% polyvinylpyrrolidon, 75 mii NaNO2 in 0.01
M cacodylate buffer, pH 7.4, subsequently for five minutes with
2% monomeric glutaraldehyde in 0.1 M cacodylate buffer, pH
7.4, and finally for one minute with 6.8% saccharose in 0.1 M
cacodylate buffer, pH 7.4 to remove the fixative. After pre-
incubation for one hour in medium without substrate, 30 tm
vibratome sections were incubated for 30 minutes at 37°C for 10
minutes in a medium consisting of 1 mtt CeCI2, 5 mM
Mg(N03)2, 2.3 mrt ATPase, and 70 mr'i Tris-maleate buffer, pH
7.2. Control sections were pretreated for four hours with 25%
glutaraldehyde or treated for one hour at 80°C before incuba-
tion. Incubations were also carried out without ATP in the
medium. After rinsing overnight at 4°C in 6.8% saccharose in
0.1 M cacodylate buffer, pH 6.0, to remove the incubation me-
dium and nonspecific precipitates, the vibratome sections were
postfixed for two hours at 4°C in 1% 0s04, 1.5% K4Fe(CN)6
in 0.1 M cacodylate buffer, pH 7.4 [5]. The vibratome sections
were subsequently rinsed at room temperature in 6.8% sac-
charose in 0.1 M cacodylate buffer, pH 7.4, until the solution
remained stainless. After dehydration in an alcohol series, the
sections were embedded in Epon 812 and processed for EM
according to standard methods.
Results
ADR treatment did not result in significant protein excretion
as measured two days after i.v. injection (proteinuria < 5 mg/24
hr, group II, Table I). In contrast, considerable protein excre-
tion occurred between week 3 and 4 after ADR treatment
(group III, Table 1) as compared to untreated animals which
were negative in this respect (group I, Table I).
Animals which had been submitted to renal ablation (group
IV) showed also proteinuria in a similar range as compared with
rats of group III, whereas ADR-treated orX-irradiated animals,
killed 48 or 24 hours after treatment, respectively, did not show
protein excretion exceeding 5 mg124 hr in their urine (groups II
and V, Table I).
As can be seen in Figure I, nucleoside phosphatase reaction
product is present throughout the GBM of untreated rats, with
the lamina rara interna (LRI) of the GBM showing relatively
high activity.
Reaction product is also observed along the plasma mem-
branes of endothelial and epithelial cells (Fig. IA), along the
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Fig. 2. A. ATPase activity in glomerular capillary segment of non-proteinuric rat 2 days after treatment with ADR (group II). The amount of
reaction product in the GBM and along the endothelial cell membranes has decreased as compared with Fig. IA. x 10,000. B. ATPase activity in
proximal tubule of the same rat as in 2A. Distribution of reaction product is identical as in non-treated rats (Fig. IB). x 4,800. Abbreviations are
the same as Fig. 1.
Fig. 3. A. ATPase activity in the glomerulus of a proleinuric rat 22 days after ADR treatment. Note the decreased amount of reaction product
in the GBM and along the plasma membranes of the endothelial cell membranes in comparison with Fig. IA. Prominent staining of plasma
membranes of epithelial cells as well as effacement of podocytes over the GBM can be seen. B. ATPase activity in another proteinuric rat of group
III 24 days after ADR treatment. In contrast to the epithelial cell membranes, again a decreased amount of reaction product in the GBM and along
the endothelial cell membranes can be seen. Fusion of epithelial podocyte is present. x 10,300. Abbreviations are the same as Fig. I.
microvilli, the lateral membranes and basal infolding of the
proximal tubules, as well as in the tubular basement membranes
(Fig. IB).
Control sections did not show enzyme reaction product.
Glomeruli of non-nephrotic rats treated with ADR (group II)
showed a decreased amount of reaction product in both GBM
as well as in endothelial cell membranes (Fig. 2A). Staining of
epithelial cell membranes was relatively less affected than in
Figure 1.
In contrast, no decrease of the amount of reaction product
could be seen in microvilli of basement membranes of proximal
tubules of these non-nephrotic animals (Fig. 2B). In nephrotic
ADR-treated rats identical decrease of reaction product could
be seen in both GBM as well as in endothelial cell membranes
(Fig. 3). The decrease of enzyme activity was found in areas of
glomerular capillary loops with or without prominent efface-
ment of podocytes (Figs. 3A and B, respectively). Again,
staining of the epithelial cell membranes was relatively unaf-
fected (Fig. 3). Reaction product in tubular structures including
microvilli, basal infoldings and tubular basement membrane, is
identical as in group Ii (Fig. 2B) or in control rats (Group I, Fig.
lB) (results not shown).
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Fig. 4. A. ATPase activity in glomerular capillary loop of a prozeinuric rat due to renal ablation, Reaction product is present throughout the GBM
and along the plasma membranes of endothelial and epithelial cells. Affacement of podocytes over the GBM is prominent. X 5,200. B. Detail of
Fig. 4A. Relatively strong staining of the lamina rara interna can be seen (compare with Fig. IA). X 19,000. Abbreviations are the same as
Fig. 1.
Fig. S. A. ATPase activity in glomerular capillary segment of a non-proteinuric X-irradiated rat (2000 rads). Note the decreased amount of
reaction product in the GBM and along the plasma membranes of endothelial and epithelial cells. x 14,000. B. Proximal tubule segment of the same
rat as in A. Note decreased amount of reaction product in the microvilli, basal infoldings and in the tubular basement membrane. X 7,200.
Abbreviations are the same as Fig. 1.
No decrease of reaction product, either in GBM or in
endothelial cell membranes, could be seen in kidneys of animals
rendered nephrotic by surgical ablation (group IV, Fig. 4). Also
in this group of nephrotic rats "fusion" of epithelial cells was
present (Fig. 4A), whereas reaction product was present
throughout the GBM (Fig. 4B) with a similar distribution as in
control rats (Fig. 1). Microvilli and other structures of proximal
tubular cells showed identical staining as in control rats.
Kidneys of X-irradiated rats (group V) showed decreased
amount of reaction product in GBM and endothelial cell mem-
tubular structures, including microvilli as illustrated in Figure
5B.
Discussion
The present results confirm previous observations indicating
that ATPase activity is present in the GBM of the rat kidney and
secondly, that a considerable decrease of this activity occurs in
rats treated with ADR [6].
In this study ATPase activity in the GBM of experimental
rats was compared with ATPase activity of the GBM of control
branes (Fig. 5A). rats. Since some variation in stainability of GBM's after each
In these rats a clear decrease of reaction product occurred in incubation may occur, due to inactivation of enzyme by perfu-
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sion fixation and variable thickness of vibratome sections,
quantitative evaluation of cytochemically stained sections can
be difficult. Therefore, we have used the ATPase activity of
tubular brush borders in each incubation as an internal stan-
dard, providing a reasonable tool for comparison of the scores
of ATPase activity in the GBM of each individual animal.
It was our aim to investigate whether or not reduced ATPase
activity in ADR-treated nephrotic rats is directly related to
proteinuria per se since demonstration of such a relationship
might shed light upon the potential function of this enzyme in
the GBM of the rat kidney.
The results show a decreased ATPase activity in the glomer-
ular filtration barrier in ADR-treated animals irrespective of the
nephrotic state (groups II and Ill, Figs. 2 and 3). In contrast, no
alteration in ATPase activity can be seen in rats rendered
nephrotic by surgical ablation of their kidneys (group IV, Fig.
4). Therefore it is likely that no direct relationship between
ATPase activity in the GBM and proteinuria exists. (In view of
the variation in podocyte morphology in normal rats—areas
with slight fusion are quite common—we feel that the present
variation in podocyte ultrastructure within experimental and
control animals without proteinuria (Figs. I, 2A and 5A) is not
significant). Whether early induced decreased glomerular
ATPase activity plays an indirect role in the proteinuria show-
ing up later on in ADR nephropathy remains to be investigated.
It may be, for instance, that proteinuria following 25 days
after ADR treatment (group III, Table I) is due to altered
epithelial cell metabolism caused by intercallation of ADR in
the epithelial cell DNA [121, irrespective of this early toxic
effect of ADR. On the other hand preliminary results, using
native ferritin as a label, point to increased glomerular perme-
ability associated with early ADR toxicity, which does not
exclude a role for these enzymes in the glomerular barrier
function.
Since early ADR toxicity is attributed to free—oxygen radical
formation and lipid peroxidation of cell membranes [10, 12—14],
it is likely that inactivation of membrane associated enzymes,
that is ATPase, is due to release of these oxygen products
reflecting a direct toxic action of ADR. Such a mechanism is
supported by a set of observations (unpublished data) including
dose dependent inhibition of the routine histochemical ATPase
reaction [15] upon cryostat kidney sections of normal rat
kidneys following preincubation with ADR (0.01; 0.02; 0.05 or
0.1 mg ADR/ml saline, respectively). Pre-incubation of the
sections with a known O2generating system, that is, xanthine
(0.33 mg/mI) and xanthine oxidase (1.70 to 6.70 gIml) [16, 17]
was also able to inhibit glomerular ATPase activity in vitro,
whereas in both ADR as well as the xanthine oxidase system
the inhibitory effect could be blocked by superoxide dismutase
(SOD) (30 U/mI).
This assumption is further supported by ATPase inactivation
in the GBM following X-irradiation (Fig. 5), known to induce
also cell membrane damage via toxic oxygen products [181.
(Interestingly, similar SOD dependent inactivation of the
ATPase activity in vitro was obtained following irradiation
[2000 radsl of normal rat kidney sections in PBS). As is shown
in Figure 5, after X-irradiation, in contrast to ADR treatment,
ATPase activity in tubular brushborders and to a lesser extent
in epithelial cell membranes, is also reduced. This more ex-
tended ATPase inactivation following X-irradiation as com-
pared with ADR treatment remains to be elucidated.
The significance of nucleoside polyphosphatases in the GBM
is unknown. However, as has been suggested for other vascular
structures in various species [19, 20] the functional significance
of these enzymes, in particular ADPase, may be associated with
its anti-thrombotic properties. Accordingly the observation that
in ADR-induced nephropathy in the rat an increased tendency
to arterial thrombosis occurs [211, may be in line with this
assumption.
It can be concluded from the present study that alteration of
the glomerular filtration barrier due to ADR treatment, as
reflected by decreased enzyme activity, represents an early
event of ADR toxicity, which starts before urinary protein
excretion occurs. Studies are in progress to elucidate the
possible contribution of early ADR toxicity as reflected by
ATPase inactivation in the GBM, upon the development of
nephrosis in this experimental model.
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